Stocksigma LogoStocksigma Logo

Alembic Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 4th Nov'26

Alembic Pharmaceuticals Limited has rescheduled its post-results conference call for analysts and institutional investors to discuss its Q2 FY27 unaudited

Alembic Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 4th Nov'26

Alembic Pharmaceuticals Ltd 路 Intimation 路 04 Nov 2026, 5:00 pm

Alembic Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 4th Nov'26 Alembic Pharmaceuticals Limited has rescheduled its post-results conference call for analysts and institutional investors to discuss its Q2 FY27 unaudited financial results. The call is now set for 4th Nov'26 at 5:00 PM IST with the senior management team. Participants can join via pre-registration through Diamond Pass or via universal dial-in numbers (+91 22 6280 1411 / +91 22 7115 8312) alongside international toll-free options for the USA, UK, Singapore, and Hong Kong.

Original exchange filing (PDF)

More announcements from Alembic Pharmaceuticals Ltd

All Alembic Pharmaceuticals Ltd announcements